Finally, a third study estimated that a treatment slowing the rate of functional decline among people with dementia by 10% would reduce total average perperson lifetime costs by $3,880 in 2015 dollars ($4,887 in 2024 dollars), while a treatment that reduces the number of behavioral and psychological symptoms by 10% would reduce total average perperson lifetime costs by $680 ($856 in 2024 dollars)
Glides smoothly without any sticky residue or heaviness
Anti inflammatory and antioxidant signaling Evidence sources : cell and animal work, narrative and mechanistic reviews Confidence : moderate on signaling changes Main caveats : shifts in biomarkers are not the same as demonstrated clinical benefit
You can purchase or obtain these from your pharmacy or doctor's office
Is There a Pharmacological Interaction
Exception: If the provider explicitly states the neuropathy is NOT related to diabetes, that providers statement governs